RYMAN HEALTHCARE LTD.RYMAN HEALTHCARE LTD.RYMAN HEALTHCARE LTD.

RYMAN HEALTHCARE LTD.

No trades
See on Supercharts
Next report date
Report period
H2 2023
EPS estimate
Revenue estimate
‪312.42 M‬EUR
Market capitalization
‪1.63 B‬EUR
‪148.85 M‬EUR
‪323.36 M‬EUR
‪598.76 M‬
Beta (1Y)
0.76

About RYMAN HEALTHCARE LIMITED NPV

Headquarters
Christchurch
Employees (FY)
‪7.2 K‬
Founded
1984
ISIN
NZRYME0001S4
FIGI
BBG000DWK029
Ryman Healthcare Ltd. engages in the development and management of integrated retirement villages for the elderly. The firm offers services, apartments, resthomes, hospitals, and provides dementia and short-term care. It operates through the following geographical segments: New Zealand and Australia. The company was founded by John William Dudley Ryder and Kevin James Hickman in 1984 and is headquartered in Christchurch, New Zealand.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange RYMAN HEALTHCARE LTD. stocks are traded under the ticker RH7.
RYMAN HEALTHCARE LTD. is going to release the next earnings report on May 27, 2024. Keep track of upcoming events with our Earnings Calendar.
RH7 earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.10 EUR resulting in a 56.18% surprise. The estimated earnings for the next quarter are 0.15 EUR per share. See more details about RYMAN HEALTHCARE LTD. earnings.
RYMAN HEALTHCARE LTD. revenue for the last quarter amounts to ‪254.52 M‬ EUR despite the estimated figure of ‪246.30 M‬ EUR. In the next quarter revenue is expected to reach ‪274.43 M‬ EUR.
Yes, you can track RYMAN HEALTHCARE LTD. financials in yearly and quarterly reports right on TradingView.
RH7 net income for the last quarter is ‪105.87 M‬ EUR, while the quarter before that showed ‪36.86 M‬ EUR of net income which accounts for 187.22% change. Track more RYMAN HEALTHCARE LTD. financial stats to get the full picture.
RYMAN HEALTHCARE LTD. dividend yield was 1.58% in 2022, and payout ratio reached 16.61%. The year before the numbers were 2.39% and 16.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, RH7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RYMAN HEALTHCARE LTD. stock right from TradingView charts — choose your broker and connect to your account.
RH7 reached its all-time high on Dec 30, 2019 with the price of 9.4530 EUR, and its all-time low was 2.2440 EUR and was reached on Apr 26, 2024.
See other stocks reaching their highest and lowest prices.
As of May 1, 2024, the company has ‪7.20 K‬ employees. See our rating of the largest employees — is RYMAN HEALTHCARE LTD. on this list?
We've gathered analysts' opinions on RYMAN HEALTHCARE LTD. future price: according to them, RH7 price has a max estimate of 4.56 EUR and a min estimate of 2.92 EUR. Read a more detailed RYMAN HEALTHCARE LTD. forecast: see what analysts think of RYMAN HEALTHCARE LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RYMAN HEALTHCARE LTD. EBITDA is ‪26.01 M‬ EUR, and current EBITDA margin is 4.79%. See more stats in RYMAN HEALTHCARE LTD. financial statements.